A detailed history of Cutter & CO Brokerage, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Cutter & CO Brokerage, Inc. holds 41,185 shares of TAK stock, worth $570,412. This represents 0.14% of its overall portfolio holdings.

Number of Shares
41,185
Previous 41,974 1.88%
Holding current value
$570,412
Previous $543,000 7.73%
% of portfolio
0.14%
Previous 0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$13.0 - $15.08 $10,257 - $11,898
-789 Reduced 1.88%
41,185 $585,000
Q2 2024

Jul 31, 2024

BUY
$12.6 - $13.67 $16,972 - $18,413
1,347 Added 3.32%
41,974 $543,000
Q1 2024

Apr 30, 2024

BUY
$13.89 - $15.04 $39,072 - $42,307
2,813 Added 7.44%
40,627 $564,000
Q4 2023

Feb 01, 2024

BUY
$13.36 - $15.43 $8,523 - $9,844
638 Added 1.72%
37,814 $539,000
Q3 2023

Oct 31, 2023

BUY
$15.03 - $16.32 $23,071 - $25,051
1,535 Added 4.31%
37,176 $575,000
Q2 2023

Aug 01, 2023

BUY
$15.57 - $17.11 $15,632 - $17,178
1,004 Added 2.9%
35,641 $559,000
Q1 2023

May 09, 2023

BUY
$15.28 - $16.48 $4,308 - $4,647
282 Added 0.82%
34,637 $570,000
Q4 2022

Feb 03, 2023

SELL
$12.42 - $15.62 $36,266 - $45,610
-2,920 Reduced 7.83%
34,355 $536,000
Q3 2022

Nov 03, 2022

SELL
$12.8 - $28.65 $58,636 - $131,245
-4,581 Reduced 10.94%
37,275 $483,000
Q2 2022

Jul 28, 2022

BUY
$13.12 - $15.03 $64,156 - $73,496
4,890 Added 13.23%
41,856 $588,000
Q1 2022

May 03, 2022

BUY
$13.54 - $15.35 $42,177 - $47,815
3,115 Added 9.2%
36,966 $529,000
Q4 2021

Feb 10, 2022

BUY
$13.17 - $16.4 $73,106 - $91,036
5,551 Added 19.61%
33,851 $461,000
Q3 2021

Nov 02, 2021

BUY
$16.3 - $17.26 $461,290 - $488,458
28,300 New
28,300 $464,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Cutter & CO Brokerage, Inc. Portfolio

Follow Cutter & CO Brokerage, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.